메뉴 건너뛰기




Volumn 173, Issue 5, 2016, Pages 722-730

A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma

(18)  Coiffier, Bertrand a   Thieblemont, Catherine b   de Guibert, Sophie c   Dupuis, Jehan d   Ribrag, Vincent e   Bouabdallah, Réda f   Morschhauser, Franck g   Navarro, Robert h   Le Gouill, Steven i   Haioun, Corinne d   Houot, Roch c   Casasnovas, Olivier j   Holte, Harald k   Lamy, Thierry c   Broussais, Florence f   Payrard, Sandrine l   Hatteville, Laurence l   Tilly, Hervé m  


Author keywords

Antibody drug conjugate; CD19; Lymphoma; Maytansinoid; Resistance

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLTUXIMAB RAVTANSINE; CREATININE; RITUXIMAB; ANTINEOPLASTIC AGENT; MAYTANSINE; MONOCLONAL ANTIBODY;

EID: 84961572840     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13992     Document Type: Article
Times cited : (55)

References (26)
  • 2
    • 34347378243 scopus 로고    scopus 로고
    • How I treat patients with diffuse large B-cell lymphoma
    • Armitage, J.O. (2007) How I treat patients with diffuse large B-cell lymphoma. Blood, 110, 29-36.
    • (2007) Blood , vol.110 , pp. 29-36
    • Armitage, J.O.1
  • 4
    • 80054095609 scopus 로고    scopus 로고
    • SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies
    • Blanc, V., Bousseau, A., Caron, A., Carrez, C., Lutz, R.J. & Lambert, J.M. (2011) SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies. Clinical Cancer Research, 17, 6448-6458.
    • (2011) Clinical Cancer Research , vol.17 , pp. 6448-6458
    • Blanc, V.1    Bousseau, A.2    Caron, A.3    Carrez, C.4    Lutz, R.J.5    Lambert, J.M.6
  • 8
    • 84864517049 scopus 로고    scopus 로고
    • Diffuse large B-cell lymphoma: current strategies and future directions
    • Cultrera, J.L. & Dalia, S.M. (2012) Diffuse large B-cell lymphoma: current strategies and future directions. Cancer Control, 19, 204-213.
    • (2012) Cancer Control , vol.19 , pp. 204-213
    • Cultrera, J.L.1    Dalia, S.M.2
  • 15
    • 84883893621 scopus 로고    scopus 로고
    • The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma
    • Lin, P. & Medeiros, L.J. (2013) The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma. Current Hematologic Malignancy Reports, 8, 243-252.
    • (2013) Current Hematologic Malignancy Reports , vol.8 , pp. 243-252
    • Lin, P.1    Medeiros, L.J.2
  • 17


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.